IL24 and B-cell chronic lymphocytic leukemia: Although high level IL-24 was linked to promoting chronic lymphocytic leukemia cell survival through activating p38 MAPK [58], several other preclinical studies demonstrated that the gene delivery of IL-24 through oncolytic adenoviruses elicited significant antileukemia effect in vitro and in vivo [19, 59].